The conditions vary, but those with IRDs may face many similar challenges, including night blindness (nyctalopia), declining vision, or blindness at birth.
Are you following the always evolving field of gene therapy research? Deepen your understanding of how researchers are approaching IRDs in this fascinating field.
Science can now decipher which gene is responsible for causing a number of IRDs. Here’s a simple overview to help you understand the basics of the genetic testing process.
Finally. Help with genetic testing.
Spark Therapeutics now offers a free gene testing initiative, designed to identify the genetic mutation responsible for certain inherited retinal diseases. Find out if you may be eligible. Participation in the initiative is subject to the terms and conditions of the initiative.
The role of the viral vector in today’s gene therapy research.
Scientists in the field of gene therapy research are working to deliver a functioning gene into the retina of the human eye, using viruses as the transporter of that gene. The viral vector is the microscopic powerhouse that holds tremendous promise in these efforts—and something you will want to know about!
We are constantly connecting with folks in the IRD community to bring new stories to aSharedVision. Check out the latest additions.
We reached out to a University of California, San Francisco clinician and researcher to get her take on the quickly evolving research landscape and the growing mandate for genetic testing. Read more
Once Victoria Romano experienced the magic of working in the classroom at Philadelphia’s Overbrook School for the Blind, she knew she’d found her calling. Read her story
There’s good news for all of you who want to learn more about the science behind genetic disease and gene therapy research. Our expanded information and new videos provide a deeper understanding of genes, chromosomes, and DNA. Read more